Brief Research Report
Published on 06 May 2022
Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.871132
- 7,418 views
- 1 citation
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,383 articles
Articles
Original Research
Published on 06 May 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.851785
- 2,781 views
- 3 citations
Original Research
Published on 06 May 2022
Obesity Does Not Increase Perioperative Outcomes in Older Patients Undergoing Thoracoscopic Anatomic Lung Cancer Surgery
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.881467
- 1,371 views
- 3 citations
Original Research
Published on 05 May 2022
Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.862564
- 1,981 views
- 4 citations
Original Research
Published on 05 May 2022
The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non–Small Cell Lung Cancer: A Population-Based Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.853257
- 1,682 views
- 2 citations
Original Research
Published on 05 May 2022
Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.843220
- 2,399 views
- 2 citations
Original Research
Published on 03 May 2022
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.833486
- 2,857 views
- 3 citations
Original Research
Published on 03 May 2022
Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and In Vitro Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.898920
- 1,482 views
- 1 citation
Original Research
Published on 03 May 2022
Gut Microbiome Was Highly Related to the Regulation of Metabolism in Lung Adenocarcinoma Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.790467
- 2,474 views
- 4 citations
Review
Published on 02 May 2022
Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.886430
- 1,972 views
- 3 citations
Original Research
Published on 29 Apr 2022
CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.867788
- 1,962 views
- 4 citations
Systematic Review
Published on 29 Apr 2022
Differential Diagnostic Value of Histology in MPLC and IPM: A Systematic Review and Meta-Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.871827
- 8,769 views
- 4 citations
Original Research
Published on 28 Apr 2022
A Multi-Classification Model for Predicting the Invasiveness of Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.800811
- 1,923 views
- 5 citations
Brief Research Report
Published on 28 Apr 2022
Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.836751
- 1,456 views
Original Research
Published on 28 Apr 2022
The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.878482
- 1,590 views
- 6 citations
Original Research
Published on 28 Apr 2022
CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.822849
- 3,670 views
- 6 citations